John Gerich
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Surgery top 5%
- Pancreatic function and diabetes
Papers in
-
- Diabetes Management and Research 4
- Diabetes Treatment and Management 3
- Surgery 2
- Pancreatic function and diabetes 2
- Co-authors
- Julio Rosenstock (1 shared paper)Matthew C. Riddle (1 shared paper)Asimina Mitrakou (2 shared papers)Walkyria de Paula Pimenta (1 shared paper)Trond Jenssen (1 shared paper)Michael Stümvoll (1 shared paper)Theo van Haeften (1 shared paper)W. Renn (1 shared paper)
- Journals
- Hormone and Metabolic Research (3 papers)Diabetes Care (3 papers)New England Journal of Medicine (1 paper)Clinical Therapeutics (1 paper)Diabetes Technology & Therapeutics (1 paper)
- Partner nations
- United StatesGermanyItaly
In The Last Decade
John Gerich
11 papers receiving 3.0k citations
John Gerich's Hit Papers
Peers
Comparison fields: 5 of 87
- Endocrinology, Diabetes and Metabolism 2.1k
- Surgery 628
- Genetics 350
- Pharmacology 198
- Physiology 226
Countries citing papers authored by John Gerich
This map shows the geographic impact of John Gerich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Gerich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Gerich more than expected).
Fields of papers citing papers by John Gerich
This network shows the impact of papers produced by John Gerich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Gerich. The network helps show where John Gerich may publish in the future.
Co-authors
The 25 scholars most cited alongside John Gerich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The Treat-to-Target Trial Hit paper breakdown → | 2003 | 1195 |
| 2 | Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Hit paper breakdown → | 2000 | 859 |
| 3 | Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD) Hit paper breakdown → | 2009 | 718 |
| 4 | 1993 | 162 | |
| 5 | 2015 | 92 | |
| 6 | 1998 | 55 | |
| 7 | 2006 | 38 | |
| 8 | 1996 | 31 | |
| 9 | 2001 | 25 | |
| 10 | 1977 | 21 | |
| 11 | 1980 | 4 |
About John Gerich
John Gerich is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Cardiology and Cardiovascular Medicine, Molecular Biology and Epidemiology, having authored 11 papers that have together received 3.2k indexed citations. Recurring topics across this work include Diabetes Management and Research (4 papers), Diabetes Treatment and Management (3 papers), Pancreatic function and diabetes (2 papers), Cardiovascular and exercise physiology (1 paper), Cardiovascular Effects of Exercise (1 paper), Diabetes and associated disorders (1 paper), Lipid metabolism and disorders (1 paper) and Neuroendocrine Tumor Research Advances (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.1k citations), Surgery (628 citations), Genetics (350 citations), Pharmacology (198 citations) and Physiology (226 citations). John Gerich has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include Julio Rosenstock, Matthew C. Riddle, Asimina Mitrakou, Walkyria de Paula Pimenta, Trond Jenssen, Michael Stümvoll, Theo van Haeften, W. Renn, H Yki-Järvinen and Sherwyn Schwartz. Their work appears in journals such as Hormone and Metabolic Research, Diabetes Care, New England Journal of Medicine, Clinical Therapeutics and Diabetes Technology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.